Company / Interest Expense
Revolution Medicines, Inc. Interest Expense History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$71.0K
FY2022
5-year range
$71.0K / $106.0K
FY2018-FY2022
Trend
-33.0%
vs FY2021
Sector context
#38 of 44
Health Care
What the data says
Revolution Medicines, Inc.'s interest expense of $71,000 is lower than 86% of companies in the Health Care sector (FY2022). Improved from $116,000 to $71,000 over the past 2 years.
Based on SEC 10-K filings.
$71,000 in FY2022 with a 3-year CAGR of -12.5%.
Improved from $116,000 to $71,000 over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- -12.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 14% in Health CareTop 14% of 44This company $71.0K Sector average $291.0M
▼
-100.0% below sector average
Key checks
Key Insights
- 3-year CAGR of -12.5%, indicating a declining trend.
- In FY2022, interest expense decreased 33.0% year-over-year.
- Ranks #38 out of 44 companies in the Health Care sector.
- Peak interest expense was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $71.0K | -33.0% |
| FY2021 | $106.0K | -8.6% |
| FY2020 | $116.0K | +9.4% |
| FY2019 | $106.0K | -8.6% |
| FY2018 | $116.0K | - |
As of FY2022 · SEC 10-K · Updated Jun 30, 2026